News & Industry Updates

Press Releases Apr 04, 2022

ReAlta Life Sciences’ RLS-0071 Demonstrates Excellent Safety Profile and Confirmed Target Engagement...

RLS-0071 is a dual action complement inhibitor and innate anti-inflammatory peptide in development as a treatment for hypoxic-ischemic encephalopathy and...

Read More
Press Releases Mar 30, 2022

FDA Clears ReAlta Life Sciences’ Phase 2 STAR Trial of RLS-0071 in...

RLS-0071 is ReAlta’s lead dual action complement inhibitor and innate anti-inflammatory peptide in development as a treatment for hypoxic-ischemic encephalopathy...

Read More
Press Releases Mar 04, 2022

ReAlta Life Sciences Announces Poster Presentation at the American Academy of Neurology...

Presenting first-in-human trial data in healthy volunteers of RLS-0071, the Company’s dual action complement inhibitor and innate anti-inflammatory product candidate...

Read More
Other Feb 22, 2022

ReAlta To Participate at Oppenheimer Annual Healthcare Conference

Norfolk, VA, February 22, 2022 – ReAlta Life Sciences, Inc. announced today that Dr. Ulrich Thienel, MD, PhD, Chief Executive Officer is scheduled...

Read More
Other Feb 09, 2022

EPICC Peptide Review Article Published – Frontiers In Immunology

The review article, “The EPICC Family of Anti-Inflammatory Peptides: Next Generation Peptides, Additional Mechanisms of Action and In Vivo and...

Read More
Other Jan 05, 2022

ReAlta to Participate At BIO – JP Morgan

Norfolk, VA, January 6th, 2022 – ReAlta Life Sciences, Inc. announced today that Dr. Ulrich Thienel, MD, PhD, Chief Executive Officer is...

Read More
Other Nov 16, 2021

MPO Data Presented at ACR 2021

Myeloperoxidase activity in individuals with Anti-neutrophil cytoplasmic antibodies (ANCA) can be inhibited by RLS-0071 At the 2021 Annual Conference of...

Read More
Other Nov 02, 2021

ReAlta to Participate in Jefferies Healthcare Conference

Norfolk, VA, November 2, 2021 – ReAlta Life Sciences, Inc. announced today that Dr. Ulrich Thienel, MD, PhD, Chief Executive Officer, will...

Read More
Other Oct 12, 2021

ReAlta to Participate in Needham Biotech Forum

Norfolk, VA, September 22, 2021 – ReAlta Life Sciences, Inc. announced today that Dr. Ulrich Thienel, MD, PhD, Chief Executive Officer and...

Read More